Join Growin Stock Community!

得生製藥7860.TW Overview

TW StockBiotech. & Medical
(No presentation for 7860)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

得生製藥（7860）Overall Performance

得生製藥（7860）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

得生製藥（7860） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

得生製藥（7860）Key Information

得生製藥（7860）Profile

得生製藥（7860）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

No related data records

default symbol

7860

得生製藥

66.80D

-0.15%

(-0.00)

  • When is 7860's latest earnings report released?

    The most recent financial report for 得生製藥 (7860) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7860's short-term business performance and financial health. For the latest updates on 7860's earnings releases, visit this page regularly.

  • How much cash does 7860 have?

    At the end of the period, 得生製藥 (7860) held Total Cash and Cash Equivalents of 368M, accounting for 0.25 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7860 go with three margins increasing?

    In the latest report, 得生製藥 (7860) achieved the “three margins increasing” benchmark, with a gross margin of 29.72%%, operating margin of 19.91%%, and net margin of 7.92%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7860's profit trajectory and future growth potential.